Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Specialty oncology company completes merger, raises $5.9 million in private financing
February 27th, 2006
Privately held Somanta Incorporated announced the completion of a reverse merger transaction with Hibshman Optical Corp., a public company with no prior operating or stock trading history. Somanta, a specialty oncology company with a focus on in-licensing and clinically developing anticancer agents, will remain as the surviving corporation with its management and board of directors assuming operational control of the combined companies. The merger will result in Somanta becoming a publicly traded company, renamed as Somanta Pharmaceuticals, Inc., trading on the Over the Counter Bulletin Board. Somanta also announced that it has raised approximately...
Source: Pharma Business Week (2006-02-27)
|
